Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information
DescriptionHealthcare Investment Group


Fund, 8/2011 $170M


Oakland, USA
One Kaiser Plaza,
22nd Floor
Oakland, CA, 94612


Managing Director
CEO, Avivia Health
Senior Vice President
Investment Banker


Kaiser Permanente Ventures

Kaiser Permanente Ventures, the corporate venture capital arm of Kaiser Permanente, is dedicated to forming effective partnerships with innovative companies. KP Venture investments are designed to:

  • Improve quality, service and affordability for KP members
  • Introduce innovative products and services to the KP organization
  • Generate attractive rates of return

Kaiser Permanente Ventures invests in medical devices, health care services and health care information technology companies that meet the following characteristics:

  • Significant innovation in delivery of care
  • Enhance KP’s quality of care, operations and cost structure
  • U.S. annual market potential >$500M
  • Experienced management team with previous successes
  • “A” round financing or later
  • Syndicate of leading venture capital healthcare investors
  • Equity position $4.0M - $5.0M

Recent Milestones


Company Date Round Size Participants
Omada Health 4/2014Series B$23M4
Vapotherm 4/2014Series B$24M8
Health Catalyst 1/2014Series C$41M5
TriVascular 11/2013Series E$40M9
Movable 6/2013Seed$1.9M5
Vapotherm 4/2013Series A$29M7
iRhythm Technologies 4/2013Series D$16M5
AtheroMed 4/2013Private Equity$5.96M4
Health Catalyst 3/2013Series B$8M2
Torax Medical 9/2012Series D$30M5
Agile Therapeutics 7/2012Series C$40M6
Oxford Immunotec 6/2012Venture Round$28M8
Astute Medical 6/2012Series C$40.4M6
TriVascular 6/2012Series D$60M7
AtheroMed 3/2012Series D$4.48M4
Transcend Medical 1/2012Series B$16M9
CytoPherx 1/2012Venture Round$34M7
iRhythm Technologies 1/2012Private Equity$12.2M4
Valeritas 9/2011Series C$150M8
Accumetrics 9/2010Venture Round$7M5
Baxano 6/2010Series C$30M6
Predictive Biosciences 6/2010Series C$25M5
Oxford Immunotec 5/2010Series D$26M7
Hemosphere 4/2010Series A$9.3M6
Accumetrics 1/2010Series E$16.6M5
ValenTx 10/2009Series B$20.3M6
Predictive Biosciences 10/2008Series B$21.8M2
Zonare Medical Systems 2/2008Venture Round$30M8
Accumetrics 2/2008Series D$28.8M7
Arcxis Biotechnologies 10/2007Series B$2M3
Bacchus Vascular 4/2007Venture Round$6.5M3
Adiana 8/2005Series D$23M9
BDNA 4/2005Series C$12.5M4
NeoGuide Systems 11/2003Series B9



  1. Kaiser Permanente Ventures Brings Fund Total To $170M, Adds To Team ( [edit]
  2. Omada Health Raises $23M Series B Led By Andreessen Horowitz For Digital Health That Actually Works ( [edit]
  3. Vapotherm Closes $24M Financing ( [edit]
  4. Health Catalyst Raises $41M For Healthcare Data Storage And Analysis ( [edit]
  5. TriVascular Closes $40M Series E Equity Financing ( [edit]
  6. Movable Raises $1.9M in Seed Funding ( [edit]
  7. Vapotherm Closes $29 Mln Round ( [edit]
  8. iRhythm Technologies Closes $16M Series D Venture Financing ( [edit]
  9. SEC ( [edit]
  10. With $41M Now In The Bank, Health Catalyst Wants To Help Solve Healthcare’s Big Data Problem ( [edit]
  11. Torax Medical Completes $30M Series D Financing ( [edit]
  12. Agile Therapeutics Closes $40M Series C Financing ( [edit]
  13. Oxford Immunotec Raises $28M in Equity Financing ( [edit]
  14. Astute Medical Completes $40.4M Series C Financing ( [edit]
  15. TriVascular Secures $60 Million in Equity Financing ( [edit]
  16. AtheroMed Raises US$4.5 Million In Series D Financing ( [edit]
  17. Transcend Medical, Inc.: Series B $16M ( [edit]
  18. CytoPherx Completes $34M Funding ( [edit]
  19. VC Funding: Q1 2012 [edit]
  20. Valeritas Raises $150m in Series C financing. ( [edit]
  21. Accumetrics Raises Additional $7M ( [edit]
  22. Baxano, Inc.: Series C $30M ( [edit]
  23. Predictive Biosciences, Inc.: Series C $25M ( [edit]
  24. Oxford Immunotec, Ltd.: Series D $26M ( [edit]
  25. Hemosphere, Inc.: Series A $9.3M ( []
  26. Accumetrics, Inc.: Series E $16.6M ( [edit]
  27. ValenTx, Inc.: Series B $20.3M ( [edit]
  28. Predictive Biosciences nails $21.75M VC round ( [edit]
  29. Compact-ultrasound maker Zonare Medical raises $30M ( [edit]
  30. Accumetrics Announces $28.8 Million Financing and Initiation of Pivotal Clinical Trial ( [edit]
  32. Bacchus, drug infusion catheter maker, to raise $6.5M more ( [edit]
  33. Adiana, Inc. Reports Completion of $23 Million Financing. ( [edit]
  34. BDNA Corporation Announces $12.5 Million in Funding; Ossama Hassanein of Newbury Ventures, Pat House of Siebel Systems, and Ernie von Simson of Ostriker von Simson Join Board of IT Governance Software Vendor ( [edit]
  35. Citation Needed [add]
Edit This Page
Last Edited 4/9/14

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy